“Immuno-Oncology – Asia Pacific – Clinical trial landscape”
The Asia-Pacific region hosted the lion’s share of cell and gene therapy clinical trials initiated in H1 2022. Find out what is drawing biotech organizations to the region and discover the resources being used to support these studies, in your free white paper from Scrip, presented in partnership with Novotech.
Immuno-Oncology (IO) has seen an explosion in development over the past five years. The Asia Pacific region is the fastest growing area globally in IO trials, with a CAGR nearing 20% between 2017 and 2021, compared to the rest of the world.
Scrip, in partnership with Novotech, invites you to explore the clinical trials landscape for IO in the APAC region.. Download your free white paper now for a data-packed look at:
Immuno-Oncology and global IO trial trends
The IO APAC clinical trial landscape by location, indication, and drug category
APAC growth drivers for IO clinical trials
The key opinion leaders (KOLs) in APAC immuno-oncology
To download your free white paper, please complete the form!
By completing this form you agree Novotech Pty Limited may store and process your personal data as well as contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy
